Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
IX-001 by Immuxell Biotech for Pancreatic Cancer: Likelihood of Approval
IX-001 is under clinical development by Immuxell Biotech and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
Data Insights
IX-001 by Immuxell Biotech for Colorectal Cancer: Likelihood of Approval
IX-001 is under clinical development by Immuxell Biotech and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...